Treatment of chronic generalized periodontitis using miramistin-containing nanomatrix as maintenance therapy: a pilot study and early results

Aim of the study was to evaluate the clinical efficacy of a nanomatrix with Miramistin based on M-Chip (Double White, Russia), which is used subgingivally as an addition to SRP (scaling and root planing) as a combination therapy in patients with chronic generalized periodontitis.Materials and method...

Full description

Bibliographic Details
Main Authors: Yu. A. Bakaev, Z. S. Khabadze, O. S. Mordanov, Yu. A. Generalova
Format: Article
Language:Russian
Published: LLC "Endo Press" 2020-10-01
Series:Эндодонтия Today
Subjects:
Online Access:https://www.endodont.ru/jour/article/view/921
_version_ 1797880101905367040
author Yu. A. Bakaev
Z. S. Khabadze
O. S. Mordanov
Yu. A. Generalova
author_facet Yu. A. Bakaev
Z. S. Khabadze
O. S. Mordanov
Yu. A. Generalova
author_sort Yu. A. Bakaev
collection DOAJ
description Aim of the study was to evaluate the clinical efficacy of a nanomatrix with Miramistin based on M-Chip (Double White, Russia), which is used subgingivally as an addition to SRP (scaling and root planing) as a combination therapy in patients with chronic generalized periodontitis.Materials and methods. T he s tudy i ncluded 4 5 p atients w ith c hronic g eneralized p eriodontitis (20 f emales a nd 25 males; age span is 35–60 years; mean age 57.87 ± 8.2 years). Patients with a probing depth ≥5 mm were included. Selected patients did not receive antibiotic therapy during the last 6 months of follow-up.Results. The mean clinical parameter values between the M-Chip + SRP treatment group and the SRP control group showed a statistically significant improvement in clinical parameters at 6 months compared to baseline values for the following indicators: plaque index (API), gingival pocket depth at probing, Mühlemann Bleeding Index (BI), the level of clinical attachment.Conclusions. SRP has been shown to be effective in reducing pocket depth, increasing periodontal attachment, and reducing inflammation. However, when SRP was used with the M-Chip, possible additional clinical benefits have been shown.
first_indexed 2024-04-10T02:58:01Z
format Article
id doaj.art-77189d1a0f1246c3968d0369e13e5597
institution Directory Open Access Journal
issn 1683-2981
1726-7242
language Russian
last_indexed 2024-04-10T02:58:01Z
publishDate 2020-10-01
publisher LLC "Endo Press"
record_format Article
series Эндодонтия Today
spelling doaj.art-77189d1a0f1246c3968d0369e13e55972023-03-13T07:39:27ZrusLLC "Endo Press"Эндодонтия Today1683-29811726-72422020-10-01183788110.36377/1683-2981-2020-18-3-78-81884Treatment of chronic generalized periodontitis using miramistin-containing nanomatrix as maintenance therapy: a pilot study and early resultsYu. A. Bakaev0Z. S. Khabadze1O. S. Mordanov2Yu. A. Generalova3Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр стоматологии и челюстно-лицевой хирургии» Министерства здравоохранения Российской ФедерацииФедеральное государственное автономное образовательное учреждение высшего образования «Российский университет дружбы народов»Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр стоматологии и челюстно-лицевой хирургии» Министерства здравоохранения Российской ФедерацииФедеральное государственное автономное образовательное учреждение высшего образования «Российский университет дружбы народов»Aim of the study was to evaluate the clinical efficacy of a nanomatrix with Miramistin based on M-Chip (Double White, Russia), which is used subgingivally as an addition to SRP (scaling and root planing) as a combination therapy in patients with chronic generalized periodontitis.Materials and methods. T he s tudy i ncluded 4 5 p atients w ith c hronic g eneralized p eriodontitis (20 f emales a nd 25 males; age span is 35–60 years; mean age 57.87 ± 8.2 years). Patients with a probing depth ≥5 mm were included. Selected patients did not receive antibiotic therapy during the last 6 months of follow-up.Results. The mean clinical parameter values between the M-Chip + SRP treatment group and the SRP control group showed a statistically significant improvement in clinical parameters at 6 months compared to baseline values for the following indicators: plaque index (API), gingival pocket depth at probing, Mühlemann Bleeding Index (BI), the level of clinical attachment.Conclusions. SRP has been shown to be effective in reducing pocket depth, increasing periodontal attachment, and reducing inflammation. However, when SRP was used with the M-Chip, possible additional clinical benefits have been shown.https://www.endodont.ru/jour/article/view/921srpm-chipпародонтитмирамистин
spellingShingle Yu. A. Bakaev
Z. S. Khabadze
O. S. Mordanov
Yu. A. Generalova
Treatment of chronic generalized periodontitis using miramistin-containing nanomatrix as maintenance therapy: a pilot study and early results
Эндодонтия Today
srp
m-chip
пародонтит
мирамистин
title Treatment of chronic generalized periodontitis using miramistin-containing nanomatrix as maintenance therapy: a pilot study and early results
title_full Treatment of chronic generalized periodontitis using miramistin-containing nanomatrix as maintenance therapy: a pilot study and early results
title_fullStr Treatment of chronic generalized periodontitis using miramistin-containing nanomatrix as maintenance therapy: a pilot study and early results
title_full_unstemmed Treatment of chronic generalized periodontitis using miramistin-containing nanomatrix as maintenance therapy: a pilot study and early results
title_short Treatment of chronic generalized periodontitis using miramistin-containing nanomatrix as maintenance therapy: a pilot study and early results
title_sort treatment of chronic generalized periodontitis using miramistin containing nanomatrix as maintenance therapy a pilot study and early results
topic srp
m-chip
пародонтит
мирамистин
url https://www.endodont.ru/jour/article/view/921
work_keys_str_mv AT yuabakaev treatmentofchronicgeneralizedperiodontitisusingmiramistincontainingnanomatrixasmaintenancetherapyapilotstudyandearlyresults
AT zskhabadze treatmentofchronicgeneralizedperiodontitisusingmiramistincontainingnanomatrixasmaintenancetherapyapilotstudyandearlyresults
AT osmordanov treatmentofchronicgeneralizedperiodontitisusingmiramistincontainingnanomatrixasmaintenancetherapyapilotstudyandearlyresults
AT yuageneralova treatmentofchronicgeneralizedperiodontitisusingmiramistincontainingnanomatrixasmaintenancetherapyapilotstudyandearlyresults